Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc

Bullboard Posts

Comment by Stocktreeon Jul 15, 2015 3:27pm

82 Views

Post# 23927339

RE:RE:Birch Hill Equity Partnership

A quick survey of the companies listed shows:

1- Information confirming they are owned solely or mainly by Birch

and/or

2- Information confirming they have a Birch-certified board member

or

3- Information not contrary to but not confirming their control

4- One should be updated (Marsulex), as I think Birch sold it.

Bullboard Posts

Canada Nickel unveils second of seven resources planned by mid-2025